 |
|
|
| |
Safety and Efficacy of Velpatasvir, Sofosbuvir and Voxilaprevir-based Regimens for the Treatment
of HCV Genotype 1-6: Results of the HCV-TARGET Study
|
| |
| |
AASLD 2019 Nov 8-12 Boston
Reported by Jules Levin
Zeuzem S, Sulkowski MS, Lim JK, Morelli GJ, Khalili M, Ben-Ari Z, Park JS, Reddy RK, Shiffman ML, Dong M, Vainorius M, Fried MW, Nelson DR, Terrault N
|
| |
|
|
|
|
|
